Taking anti-HIV drugs can dramatically reduce the risk of you passing on HIV to your baby.
There is a set of effective strategies that prevent mother-to-child transmission (MTCT) from taking place. These are called PMTCT - prevention of mother-to-child transmission.
Many women living with HIV have given birth to HIV-negative children by taking these precautions:
By doing these things, the chances of the baby having HIV become very low – under 1%. If you are on HIV treatment and have an undetectable viral load, the chances are lower still: 0.1%.
There are two different ways in which anti-HIV drugs act to prevent mother-to-child transmission.
First, they reduce your viral load so your baby is exposed to less HIV while in the womb and during birth. The aim of HIV treatment is to get, and keep, your viral load to undetectable levels (if your viral load is below 50, it is usually said to be undetectable).
Second, anti-HIV drugs may cross the placenta and enter your baby’s body, preventing the virus from ever taking hold. Newborn babies are given a short course of anti-HIV drugs after they are born when their mother is known to be HIV positive.
You can reduce the risk of HIV transmission further by having a managed delivery. Your doctor will look at your viral load when you are 36 weeks pregnant and discuss options with you.
If you have an undetectable viral load, it is usually recommended that you have a vaginal delivery. You will need to continue with your HIV treatment during labour.
If your viral load is detectable, but very low (under 400), your doctor will look at your particular situation and discuss options with you.
If your viral load is above 400, it is recommended you have a planned caesarean section.
Your baby should start four weeks of anti-HIV drugs in the first four hours after he or she is born, and will have an HIV test in the first 48 hours. Further tests will be done in the next months to find out his or her HIV status.
It's important to remember that you should not breastfeed your baby if you have HIV as HIV is present in breast milk.
This article was last reviewed on
by R. Bignami
Date due for the next review: 1/7/2016
Content Author: S. Corkery (NAM)
Current Owner: G.Hughson (NAM)
Townsend C et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22: 973-981, 2008 de Ruiter A et al. Guidelines for the management of HIV infection in pregnant women 2012 (updated May 2014) BHIVA, 2014
Various people talk about the effect HIV has had on their everyday health
CAB - Citizens Advice Bureau
HIV Drug Interactions
George House Trust
Equality and Human Rights Commission
Copyright 2013 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527)
Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986)